Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,542 | -6,553 | -2,703 | -5,360 | 3,121 |
| Depreciation Amortization | 557 | 2,421 | 1,851 | 1,257 | 646 |
| Accounts receivable | -2,072 | -8,883 | -7,300 | -6,482 | -1,379 |
| Accounts payable and accrued liabilities | -1,113 | 1,796 | 1,430 | 1,255 | 1,523 |
| Other Working Capital | -5,054 | -2,901 | -1,871 | -4,560 | -328 |
| Other Operating Activity | 1,624 | -51,430 | -41,804 | -23,525 | -20,942 |
| Operating Cash Flow | $-18,600 | $-65,550 | $-50,397 | $-37,415 | $-17,359 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -276 | -1,194 | -563 | -287 | -158 |
| Investing Cash Flow | $-276 | $-1,194 | $-563 | $-287 | $-158 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,722 | 3,722 | 3,722 | N/A |
| Debt Repayment | N/A | -4,167 | -4,167 | -4,167 | -2,083 |
| Common Stock Issued | 129 | 3,571 | 2,629 | 1,950 | 922 |
| Other Financing Activity | 0 | -275 | 0 | 0 | -1 |
| Financing Cash Flow | $129 | $2,851 | $2,184 | $1,505 | $-1,162 |
| Beginning Cash Position | 165,928 | 229,821 | 229,821 | 229,821 | 229,821 |
| End Cash Position | 147,181 | 165,928 | 181,045 | 193,624 | 211,142 |
| Net Cash Flow | $-18,747 | $-63,893 | $-48,776 | $-36,197 | $-18,679 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,600 | -65,550 | -50,397 | -37,415 | -17,359 |
| Capital Expenditure | -276 | -1,194 | -563 | -287 | -158 |
| Free Cash Flow | -18,876 | -66,744 | -50,960 | -37,702 | -17,517 |